CA Patent

CA2916535A1 — Method for treating otic infections after tympanostomy tube placement

Assigned to Merlion Pharmaceuticals Pte Ltd · Expires 2015-02-19 · 11y expired

What this patent protects

The present invention relates to methods for treating a microbial infection comprising administering a composition comprising one or more antibiotic compounds to the site of the infection by instilling the composition into the tympanostomy tube. A delivery cannula can be used to …

USPTO Abstract

The present invention relates to methods for treating a microbial infection comprising administering a composition comprising one or more antibiotic compounds to the site of the infection by instilling the composition into the tympanostomy tube. A delivery cannula can be used to instill the composition into the tympanostomy tube.

Drugs covered by this patent

Patent Metadata

Patent number
CA2916535A1
Jurisdiction
CA
Classification
Expires
2015-02-19
Drug substance claim
No
Drug product claim
No
Assignee
Merlion Pharmaceuticals Pte Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.